Yangmu Huang

Dados Biográficos

ID7870113
NOMEYangmu Huang
PRENOMESYangmu
SOBRENOMEHuang
ASSINATURAHUANG Y
AFILIAÇÕESPeking University
ORCID0000-0002-3660-1276
VERIFICADOSim
TOTAL DE OBRAS9
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR9
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2021
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H0

  • Global disparities in regulatory approval of prophylactic vaccines, 2005–2024

    Open AccessRizhen Wang, Jing Chen et al.ARTICLEJournal of Global Health2026

    Background: Timely approval of prophylactic vaccines is essential to equitable access, especially in low- and middle-income countries (LMICs) disproportionately affected by vaccine-preventable diseases. In this cross-sectional analysis, we characterised the global landscape of regulatory approvals for new prophylactic vaccines over the past two decades. Methods: We retrieved data from Pharmaprojects for new prophylactic vaccines approved globally…

  • Implementing public health emergency operations centres according to an international framework in Ethiopia, Nigeria, and Senegal

    Open AccessSenait Tekeste Fekadu, Jian Li et al.ARTICLEPLOS Global Public Health2026

    A public health emergency operations centre (PHEOC) is a hub for effective coordination of information and resources. Countries have established PHEOCs as part of the effort to strengthen their emergency management capabilities. However, there is limited documented evidence of best practices in PHEOC implementation in accordance with the world health organization PHEOC framework. A survey was conducted to document best practices and experiences i…

  • International collaborative research and development (R&D) on traditional medicine and its contextual factors

    Open AccessYinuo Sun, Jiyan Ma et al.ARTICLEJournal of Global Health2026

    Background: Traditional medicines can contribute to achieving universal health coverage, particularly in low- and middle-income countries where access to conventional treatments is limited. International collaboration is crucial to bridge the lag in modernised research and promote access to traditional medicines. This study focused on China's global collaborative research and development (R&D) efforts on traditional medicine, in the hope of impro…

  • China’s position and competitiveness in the global antibiotic value chain

    Open AccessYang Yang, Lewis Husain et al.ARTICLEGlobalization and Health2024

    BACKGROUND: Antibiotics are a key commodity for global health, and inadequate access is a major contributor to global mortality. COVID-19 has refocused attention on global pharmaceutical value chains and the need for sustainable and secure production and supply of key products, including antibiotics. Production of antibiotics and their active pharmaceutical ingredients is capital- and technology-intensive, however, and value chains are dominated …

  • Towards mission-driven investment in new antimicrobials? What role for Chinese strategic industrial financing vehicles in responding to the challenge of antimicrobial resistance

    Open AccessLewis Husain, Yajing Hu et al.ARTICLEGlobalization and Health2024

    BACKGROUND: Antimicrobial resistance (AMR) causes high levels of global mortality. There is a global need to develop new antimicrobials to replace those whose efficacy is being eroded, but limited incentive for companies to engage in R&D, and a limited pipeline of new drugs. There is a recognised need for policies in the form of 'push' and 'pull' incentives to support this R&D. This article discusses China, a country with a rapidly emerging pharm…

  • Regulatory reliance for convergence and harmonisation in the medical device space in Asia-Pacific

    Open AccessMing Xu, Li Zhang et al.ARTICLEBMJ Global Health2022

    While some sort of regulatory convergence and harmonisation are often needed for achieving regulatory reliance, in reality, regulatory reliance as a strategy towards convergence and harmonisation has never been more significant in Asia-Pacific (APAC). A sustained, rapid and large-scale provision of medical devices, including articles and apparatus used in diagnosis, care, treatment or prevention of disease and softwares, etc, across national boun…

  • Improving Innovation and Access to Combination Vaccines for Childhood Immunization in China

    Open AccessJiyan Ma, Zhuo Li et al.ARTICLEInternational Journal of…2022

    using a combined approach, with cross-country and multi-disciplinary support from experts, our research is designed to fill the information gaps in China's combination vaccine industry across the innovation-access spectrum. It will lead to evidence-based recommendations which will foster greater access to innovation-enhancing combination vaccines for childhood immunization in China. Moreover, the multi-dimensional approach could also be adapted b…

  • Research capacity of global health institutions in China

    Open AccessXiaoxiao Jiang Kwete, Kun Tang et al.ARTICLEBMJ Global Health2021

    INTRODUCTION: This paper presented qualitative and quantitative data collected on the research capacity of global health institutions in China and aimed to provide a landscaping review of the development of global health as a new discipline in the largest emerging economy of the world. METHODS: Mixed methods were used and they included a bibliometric analysis, a standardised survey and indepth interviews with top officials of 11 selected global h…

  • Knowledge, Attitudes, and Practices Related to Covid-19 Among Malawi Adults

    Open AccessYutong Li, Guangqi Liu et al.ARTICLEInternational Journal of…2021

    A low level of KAP was detected among the population. The people faced challenges regarding a lack of necessary preventive resources and formal information channels. The situation was worse considering vulnerable population who had low economic status. Further all-round health education is urgently needed along with providing adequate health supplies and ensuring proper information management